Interesting comments on FDA AE Draft Guidance


Here are some interesting comments on the FDA Draft Guidance “Guidance for Clinical Investigators, Sponsors, and IRBs: Adverse Event Reporting to IRBs – Improving Human Subject Protection” by my friend Erica Heath, President of IRC-IRB. She points out that IRBs need unexpected problems reported as well as AEs. She notes that “all AEs are problems but not all problems are AEs.” Recommended reading in all your spare time:

irc_comments_re_fda_733a5e

Read additional posts on Good Clinical Practice- GCP:

https://carl1anderson.wordpress.com/category/gcp/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: